Gilead Sciences, Inc.
GILD
$134.43
-$1.79-1.31%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 9.22B | 8.51B | 8.11B | 6.31B | 5.97B |
| Total Depreciation and Amortization | 2.75B | 2.76B | 2.77B | 2.77B | 2.77B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.46B | 2.70B | 1.65B | 2.71B | 3.08B |
| Change in Net Operating Assets | -3.63B | -3.95B | -2.86B | -1.92B | -1.45B |
| Cash from Operations | 10.81B | 10.02B | 9.67B | 9.87B | 10.37B |
| Capital Expenditure | -576.00M | -563.00M | -505.00M | -499.00M | -522.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -906.00M | -1.07B | -536.00M | -939.00M | -1.07B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.13B | -3.16B | -2.14B | -2.03B | -65.00M |
| Cash from Investing | -2.61B | -4.79B | -3.18B | -3.47B | -1.66B |
| Total Debt Issued | -- | -- | 3.46B | 3.46B | 3.46B |
| Total Debt Repaid | -2.79B | -1.79B | -1.79B | -1.89B | -3.73B |
| Issuance of Common Stock | 322.00M | 408.00M | 549.00M | 550.00M | 528.00M |
| Repurchase of Common Stock | -1.61B | -1.92B | -2.04B | -1.91B | -1.48B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.03B | -4.00B | -3.98B | -3.96B | -3.94B |
| Other Financing Activities | -444.00M | -440.00M | -424.00M | -369.00M | -340.00M |
| Cash from Financing | -8.56B | -7.75B | -4.22B | -4.11B | -5.50B |
| Foreign Exchange rate Adjustments | 62.00M | 92.00M | 32.00M | 81.00M | -3.00M |
| Miscellaneous Cash Flow Adjustments | 1.00M | 0.00 | 0.00 | 1.00M | -- |
| Net Change in Cash | -297.00M | -2.43B | 2.29B | 2.37B | 3.21B |